Manufacturer record
Dr. Reddys Laboratories: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Dr. Reddys Laboratories (Andhra Pradesh) was declared Not of Standard Quality in October 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: H230266, Decitabine for Injection 50 mg / vial (exp Feb 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Water Content. Listed in the October 2024 alert.
Records by type
1 record linked to Dr. Reddys Laboratories in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Decitabine for Injection 50 mg / vial | Batch H230266Mfg Mar 2023 · Exp Feb 2025 | Water ContentWater content | CDL KolkataCDSCO lab | Oct 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.